INO - Inovio Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INO is currently covered by 7 analysts with an average price target of $15.66. This is a potential upside of $13.29 (560.76%) from yesterday's end of day stock price of $2.37.

Inovio Pharmaceuticals's activity chart (see below) currently has 97 price targets and 118 ratings on display. The stock rating distribution of INO is 54.55% HOLD and 45.45% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72.01% with an average time for these price targets to be met of 495.25 days.

Highest price target for INO is $18, Lowest price target is $3, average price target is $9.11.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 14-Aug-2025. First documented stock forecast 18-Jun-2014.

Currently out of the existing stock ratings of INO, 12 are a HOLD (54.55%), 10 are a BUY (45.45%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$3

$0.63 (26.58%)

$3

16 days ago
(14-Aug-2025)

3/8 (37.5%)

$1.38 (85.19%)

1200

Buy

$5

$2.63 (110.97%)

$72

1 months 21 days ago
(09-Jul-2025)

7/8 (87.5%)

$3.55 (244.83%)

548

Hold

$5

$2.63 (110.97%)

$5

3 months 16 days ago
(14-May-2025)

13/20 (65%)

$3.12 (165.96%)

417

Buy

$13

$10.63 (448.52%)

$15

3 months 16 days ago
(14-May-2025)

0/3 (0%)

$11.12 (591.49%)

Buy

$18

$15.63 (659.49%)

5 months 16 days ago
(14-Mar-2025)

1/2 (50%)

$15.97 (786.70%)

67

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INO (Inovio Pharmaceuticals) average time for price targets to be met?

On average it took 495.25 days on average for the stock forecasts to be realized with a an average price target met ratio 72.01

Which analyst has the current highest performing score on INO (Inovio Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on INO (Inovio Pharmaceuticals)?

Charles Duncan works at CANTOR FITZGERALD and has 12 price targets and 8 ratings on INO

Which analyst is the currently most bullish on INO (Inovio Pharmaceuticals)?

Thomas Shrader with highest potential upside - $129.63

Which analyst is the currently most reserved on INO (Inovio Pharmaceuticals)?

Jason Kolbert with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?